Overview

Evaluation of Patients With Bulky GIST Using Sunitinib

Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine if oral (mouth) delivery prior to tumor removal in patients with gastrointestinal stromal tumor (GIST) results in tumor shrinkage allowing for successful surgery. Therapy will be administered orally and the response of the tumor will be assessed using CTs or MRIs.
Phase:
N/A
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
Pfizer
Treatments:
Sunitinib